Levocetirizine Dihydrochloride Tablet
Product Images NDC 68462-346

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 68462-346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl5mg90s

Packaging label for Levocetirizine Dihydrochloride Tablets USP, 5 mg, oral tablet form. The label indicates a container holding 90 tablets, manufactured and labeled by Glenmark Pharmaceuticals Inc., USA. The label includes the NDC number 68462-346-90 and instructions related to storage and administration.*

FDA Label Image

Logo

LEVOCETIRIZINE DIHYDROCHLORIDE 5 mg tablet packaging label from Glenmark Pharmaceuticals Inc., USA. The label shows the brand name "Glenmark" with the proprietary name prominently displayed. The dosage strength is 5 mg, and the form is oral tablet. The label is primarily white with text and the Glenmark logo.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of levocetirizine dihydrochloride, showing the molecular framework including chlorine-substituted phenyl, piperazine ring, and carboxylic acid groups with two hydrochloride components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.